Microbot Medical
MBOT
39 hedge funds and large institutions have $9.98M invested in Microbot Medical in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
5% more funds holding
Funds holding: 37 → 39 (+2)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
21% less capital invested
Capital invested by funds: $12.6M → $9.98M (-$2.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$7.86M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.61M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$881K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$135K |
| 5 |
Goldman Sachs
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$551K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$396K |
| 3 |
Jane Street
New York
|
-$271K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$76.5K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$42K |
MBOT Hedge Fund Activity: Q3 2014 in Review
39 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2014, worth a combined $9.98M — down 21% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $7.86M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $551K sold.
- 39 institutional investors held Microbot Medical (MBOT) as of Q3 2014, up from 37 in Q2 2014.
- Funds reported $9.98M of Microbot Medical stock for Q3 2014, down 21% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q3 2014 and 5 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q3 2014 was Sabby Management, an estimated $7.86M added.
- The largest Microbot Medical seller in Q3 2014 was Perceptive Advisors, an estimated $551K sold.
Based on aggregated 13F filings for Q3 2014.